Considering the great difference between the patients with MDD in IL-6, and only around 30% of patients with MDD showed signs of inflammation, the study divided the patients into higher, medium, and lower subgroups based on their baseline IL-6. This evidence concerns the gene IL6 and major depressive disorder.